Trial Information
Gamma-H2AX as a Molecular Predictor of Prostate Cancer Radiosensitivity
Inclusion Criteria:
- prostate cancer diagnosis
- undergoing radiotherapy
- agree to participate in study
Exclusion Criteria:
- not willing to participate
- not undergoing radiotherapy
Type of Study:
Observational
Study Design:
Observational Model: Case-Only, Time Perspective: Prospective
Principal Investigator
Nadeem Pervez, MBBS, FRCPC
Investigator Role:
Principal Investigator
Investigator Affiliation:
Alberta Health Services
Authority:
Canada: Health Canada
Study ID:
GU-6-0076/ethics 23586
NCT ID:
NCT00523471
Start Date:
July 2007
Completion Date:
June 2010
Related Keywords:
- Prostate Cancer
- prostate cancer
- gamma H2AX
- radiosensitivity
- Prostatic Neoplasms